CILIAN develops an innovative Influenza subunit vaccine together with European collaborative research programme ADITEC.

“CILIAN AG is now an affiliated member of the European collaborative research programme Advanced Immunization Technologies (ADITEC). Within this consortium CILIAN intends to improve efficacy of its own seasonal influenza subunit vaccine CiFlu® (brand name in Europe) using novel and powerful immunization technologies. CILIAN’s vaccine already features significant improvements in production speed and cost of goods as compared to currently available products which may be further improved substantially in this collaboration.”